HowardSchankerMD
Allergy & Immunology • Los Angeles, CAClinical & Laboratory Immunology
Assistant Professor of Medicine, UCLA-David Geffen School of Medicine
Are you Dr. Schanker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
11620 Wilshire Blvd
Suite 200
Los Angeles, CA 90025Phone+1 310-312-5050Fax+1 310-575-9292
Summary
- Dr. Howard Schanker, MD is an allergist/immunologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is an Assistant Professor of Medicine at UCLA-David Geffen School of Medicine.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Allergy and Immunology, 1982 - 1983
Kaiser Permanente Southern California (Los Angeles)Residency, Internal Medicine, 1978 - 1980
Brigham and Women's HospitalInternship, Internal Medicine, 1977 - 1978
State University of New York Downstate Medical Center College of MedicineClass of 1977
Certifications & Licensure
CA State Medical License 1978 - 2019- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Publications & Presentations
PubMed
- 17 citationsOnset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditionsJonathan Corren, Gary S. Rachelefsky, Sheldon L. Spector, Howard M. Schanker, Sheldon C. Siegel
The Journal of Allergy and Clinical Immunology. 1999-04-01 - 2 citationsScuba diving in individuals with asthmaHoward M. Schanker, Sheldon L. Spector
Allergy and Asthma Proceedings. 1996-11-01 - 60 citationsComparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthmaSheldon L. Spector, Christopher F. Nicodemus, Jonathan Corren, Howard M. Schanker, Gary S. Rachelefsky
The Journal of Allergy and Clinical Immunology. 1995-08-01
Professional Memberships
- Fellow
